Product Details

These film-coated tablets meet British Pharmacopoeia standards, delivering reliable blood pressure control. Physicians widely prescribe this fixed-dose combination to manage essential hypertension, especially when a single agent doesn’t achieve adequate control.

The tablets combine:

• Telmisartan BP (40 mg) — an Angiotensin II Receptor Blocker (ARB) that relaxes blood vessels by blocking the action of angiotensin II, lowering blood pressure and reducing cardiovascular strain
• Hydrochlorothiazide BP (12.5 mg) — a thiazide diuretic that helps the kidneys eliminate excess sodium and water, reducing blood volume and further supporting blood pressure control

Together, these two mechanisms complement each other. As a result, VERTEL-H offers more consistent 24-hour blood pressure management than either agent alone. Because of this dual action, physicians often prescribe it for patients who need step-up therapy or who haven’t responded fully to monotherapy. Therefore, doctors rely on it across hospitals, cardiology clinics, and general outpatient settings.

Key Features

• Meets BP (British Pharmacopoeia) standards for consistent quality
• Combines an ARB with a thiazide diuretic for dual-action control
• Delivers improved stability and easy swallowing through its film coating
• Ensures accurate, validated dosing in every batch
• Suits pharmacy, hospital, and institutional supply needs
• Follows GMP-compliant manufacturing processes